Alvotech SA

18 wrz 2026, 23:01 UTC

Alvotech SA is trading higher in after-market hours, maintaining a position significantly above its 20-day moving average after four consecutive sessions of gains.

17 wrz 2026, 22:11 UTC

Alvotech SA is advancing in after-market trading, continuing its upward trend and remaining well above its 20-day moving average.

16 wrz 2026, 23:01 UTC

Alvotech SA is trading higher in after-market hours, remaining above its 20-day moving average despite a notable decline from an early session high.

14 wrz 2026, 20:08 UTC

Alvotech SA shares are lower today, continuing a decline that began earlier in the session, reversing recent gains from the past three days.

11 wrz 2026, 19:36 UTC

Alvotech SA shares are higher, reflecting intraday strength amid broader market dynamics, including U.S. Consumer Price Index data influencing inflation expectations.

10 wrz 2026, 20:07 UTC

Alvotech SA shares are higher as the European Central Bank raised interest rates by 25 basis points, influencing market dynamics. No specific company news was identified.

9 wrz 2026, 20:07 UTC

Alvotech SA shares are lower today, marking a fourth consecutive decline. The broader market faces pressure from rising crude oil prices above $100 per barrel.

8 wrz 2026, 20:03 UTC

Alvotech SA shares are lower today, having declined since Friday's close. The stock reached a session low before partially recovering.

3 wrz 2026, 19:56 UTC

Alvotech SA shares are trading roughly flat, with no specific news identified. The stock remains significantly above its 20-day moving average.

2 wrz 2026, 21:02 UTC

Alvotech SA shares are lower in after-market hours, continuing recent downward momentum amid a disappointing ADP report on slower job growth.

1 wrz 2026, 20:08 UTC

Alvotech SA shares are trading lower amid broader market trends. Rising oil prices and inflation concerns are influencing market expectations for interest rate hikes.

31 sie 2026, 20:03 UTC

Alvotech SA shares are higher after the FDA accepted its Biologics License Application for AVT80, a proposed interchangeable biosimilar to Entyvio.

28 sie 2026, 20:07 UTC

Alvotech SA shares are rising after Bank of America initiated coverage with a Buy rating and a $7 price target.

26 sie 2026, 19:51 UTC

Alvotech SA shares are lower today amid broader market pressures. Inflationary concerns from recent PCE data may influence Federal Reserve policy discussions.

25 sie 2026, 19:16 UTC

Alvotech SA shares are lower today after a morning peak. No specific news has been identified to explain the price movement.

24 sie 2026, 23:16 UTC

Alvotech SA shares are trading roughly flat in after-market hours. The stock has gained significantly over the past month, remaining above its 20-day moving average.

21 sie 2026, 19:51 UTC

Alvotech SA has signed a licensing agreement with Lotus Pharmaceutical for two biosimilars, potentially generating $150 million in payments, as shares trade higher.

20 sie 2026, 20:02 UTC

Alvotech reaffirms 2026 revenue guidance amid Q2 revenue decline.

19 sie 2026, 23:01 UTC

Alvotech SA reaffirmed its 2026 sales guidance of $650 million to $700 million, boosting investor sentiment and driving shares higher in after-market trading.

18 sie 2026, 19:16 UTC

Alvotech SA shares are higher today, maintaining a cumulative gain since Monday. The stock is above its 20-day moving average and near its one-month high.

17 sie 2026, 21:02 UTC

Alvotech SA shares rose during after-market hours, reaching a high of 2.84%. The price is above its 20-day moving average and near a one-month high.

14 sie 2026, 19:56 UTC

Alvotech SA shares are trading roughly flat amid broader market sentiment influenced by a decline in U.S. retail sales for July.

13 sie 2026, 20:06 UTC

Alvotech SA shares are higher during Thursday's session, continuing an upward trend since Wednesday's close, trading above its 20-day moving average.

12 sie 2026, 19:31 UTC

Alvotech SA shares are trading higher, reflecting market optimism after recent inflation data showed core CPI aligned with forecasts. No specific company news was identified.

11 sie 2026, 19:26 UTC

Alvotech's Reykjavik facility receives Voluntary Action Indicated status from the FDA, allowing advancement of multiple Biologics License Applications. Shares are trading higher.

10 sie 2026, 20:06 UTC

Alvotech SA will release its financial results for the first half of 2026 on August 19, after the U.S. market close. Shares are little changed.

6 sie 2026, 20:06 UTC

Alvotech SA shares are higher today, trading above their 20-day moving average and near the upper end of their one-month range. No specific news was identified.

5 sie 2026, 19:56 UTC

Alvotech SA shares are lower during Wednesday's session, continuing a decline since Tuesday's close amid broader market trends and falling oil prices.

4 sie 2026, 19:52 UTC

Alvotech SA shares are higher today, supported by declining crude oil prices easing inflation concerns. The stock remains above its 20-day moving average.

3 sie 2026, 19:51 UTC

Alvotech SA shares are lower today, reflecting a sharp decline despite a brief rebound earlier in the session. No specific news was identified for the drop.